Neural Therapeutics Inc.
Share Statistics
As of January 31, 2026, NEURAL THERAPEUTICS INC has 168.70M shares outstanding.
| Shares Outstanding | 168.70M |
Financial Position
As of January 31, 2026, NEURAL THERAPEUTICS INC maintains a current ratio of 0.39, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.39 |
| Quick Ratio | 0.38 |
Financial Efficiency
These figures cover the twelve months ended January 31, 2026. Return on assets (ROA) is negative at -114.98, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -114.98 |
Income Statement
USDOver the twelve months ended January 31, 2026, NEURAL THERAPEUTICS INC generated - - in revenue and converted that into -929,174.69 in net income, yielding earnings per share of -0.01. EBITDA reached -730,442.70, while operating income came in at -712,524.43.
| Operating Income | -712,524.43 |
| Pretax Income | -929,174.69 |
| Net Income | -929,174.69 |
| EBITDA | -730,442.70 |
| EBIT | -730,442.70 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
USDThese figures are as of January 31, 2026. Total book value stands at 479,895.38, with working capital of -81,933.32 providing operational flexibility.
| Cash & Cash Equivalents | 46,129.83 |
| Net Debt | -46,129.83 |
| Equity (Book Value) | 479,895.38 |
| Working Capital | -81,933.32 |
Cash Flow
USDNEURAL THERAPEUTICS INC produced -300,820.61 in operating cash flow over the twelve months ended January 31, 2026.
| Operating Cash Flow | -300,820.61 |
| Free Cash Flow | -300,820.61 |